Huntsman Announces That Venator Prices Its IPO

THE WOODLANDS, Texas, Aug. 2, 2017 /PRNewswire/ -- Huntsman Corporation (NYSE: HUN) announced its subsidiary, Venator Materials PLC ("Venator"), a global chemical company dedicated to the development and manufacture of titanium dioxide ("TiO2") pigments and performance additives, today announced the pricing of its initial public offering ("IPO") of 22,700,000 ordinary shares at an initial offering price of $20.00 per share for total gross proceeds (before underwriters' fees and estimated expenses) of $454 million. All of the ordinary shares will be sold by Huntsman Corporation, and Venator will not receive any proceeds from the offering. Huntsman Corporation has granted the underwriters a 30-day option to purchase up to an additional 3,405,000 ordinary shares.  Venator's ordinary shares are expected to be listed, and begin trading, on the New York Stock Exchange on August 3, 2017 under the ticker symbol "VNTR."

Upon closing of the offering, the public will hold approximately 21.4% of Venator's ordinary shares, or 24.6% if the underwriters exercise in full their option to purchase additional ordinary shares.  Huntsman will own the remaining 78.6% of Venator's ordinary shares, or 75.4% if the underwriters exercise in full their option to purchase additional ordinary shares.

Citigroup, Goldman Sachs & Co. LLC, BofA Merrill Lynch and J.P. Morgan have acted as lead book-running managers for the offering. Additional book-running managers were Barclays, Deutsche Bank Securities, UBS Investment Bank and RBC Capital Markets. Co-managers were Moelis & Company, HSBC, Nomura, SunTrust Robinson Humphrey, Academy Securities and Commerzbank.  The offering of these securities is being made only by means of a prospectus that meets the requirements of Section 10 of the Securities Act of 1933.

If you liked this article you might like

Fed, Toys 'R' Us, Equifax and Hurricane Maria - 5 Things You Must Know

White Tale Increases Clariant Stake, Repeats Opposition to Huntsman Merger

Vantiv-Worldpay Deal an Inversion That Wasn't

Clariant Enlists Goldman to Help Fend Off Activist Group

New Tronox Chairman Faces Test at Coatings and Pigments Maker